Abstract
Original language | English |
---|---|
Pages (from-to) | 140-152 |
Number of pages | 13 |
Journal | European Journal of Cancer |
Volume | 77 |
DOIs | |
Publication status | Published - 2017 |
Keywords
- Cancer registries
- EUROCARE
- Europe
- Papillary
- Relative survival
- Thyroid cancer
- adult
- age
- Article
- cancer diagnosis
- cancer incidence
- cancer mortality
- cancer registry
- cancer survival
- cohort analysis
- Croatia
- female
- France
- human
- Ireland
- major clinical study
- male
- mortality rate
- Northern European
- oncological parameters
- priority journal
- relative survival
- sex
- Southern Europe
- survival rate
- survival time
- thyroid cancer
- thyroid papillary carcinoma
- adenocarcinoma
- adolescent
- aged
- carcinoma
- clinical trial
- demography
- diagnosis related group
- epidemiology
- incidence
- middle aged
- mortality
- multicenter study
- register
- sex ratio
- statistics and numerical data
- thyroid tumor
- young adult
- Adenocarcinoma, Follicular
- Adolescent
- Adult
- Aged
- Carcinoma
- Diagnosis-Related Groups
- Female
- Humans
- Incidence
- Male
- Middle Aged
- Registries
- Residence Characteristics
- Sex Distribution
- Thyroid Neoplasms
- Young Adult
Fingerprint
Dive into the research topics of 'Survival of 86,690 patients with thyroid cancer: A population-based study in 29 European countries from EUROCARE-5'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
Survival of 86,690 patients with thyroid cancer: A population-based study in 29 European countries from EUROCARE-5. / Dal Maso, L.; Tavilla, A.; Pacini, F. et al.
In: European Journal of Cancer, Vol. 77, 2017, p. 140-152.Research output: Contribution to journal › Article › peer-review
}
TY - JOUR
T1 - Survival of 86,690 patients with thyroid cancer: A population-based study in 29 European countries from EUROCARE-5
AU - Dal Maso, L.
AU - Tavilla, A.
AU - Pacini, F.
AU - Serraino, D.
AU - van Dijk, B.A.C.
AU - Chirlaque, M.D.
AU - Capocaccia, R.
AU - Larrañaga, N.
AU - Colonna, M.
AU - Agius, D.
AU - Ardanaz, E.
AU - Rubió-Casadevall, J.
AU - Kowalska, A.
AU - Virdone, S.
AU - Mallone, S.
AU - Amash, H.
AU - De Angelis, R.
AU - Hackl, M.
AU - Zielonke, N.
AU - Van Eycken, E.
AU - Gatta, G.
AU - Sant, M.
AU - Amati, C.
AU - Baili, P.
AU - Berrino, F.
AU - Bonfarnuzzo, S.
AU - Botta, L.
AU - Di Salvo, F.
AU - Foschi, R.
AU - Margutti, C.
AU - Meneghini, E.
AU - Minicozzi, P.
AU - Trama, A.
AU - Zucchetto, A.
AU - Caldora, M.
AU - Francisci, S.
AU - Pierannunzio, D.
AU - Rossi, S.
AU - Santaquilani, M.
AU - Filiberti, R.A.
AU - Fusco, M.
AU - Vitale, M.F.
AU - Mangone, L.
AU - Vicentini, M.
AU - Falcini, F.
AU - Rocca, A.
AU - Tagliabue, G.
AU - Contiero, P.
AU - Tognazzo, S.
AU - Sanchez, M.J.
AU - Roazzi, Paolo
AU - Group, EUROCARE-5 Working
AU - Carrani, E.
N1 - Cited By :5 Export Date: 9 April 2018 CODEN: EJCAE Correspondence Address: Dal Maso, L.; Cancer Epidemiology Unit, CRO Aviano National Cancer Institute IRCCS, Via Franco Gallini 2, Italy; email: epidemiology@cro.it Funding details: 16921, AIRC, Associazione Italiana per la Ricerca sul Cancro Funding details: 20102202 Funding details: 2010.1354, Compagnia di San Paolo Funding details: EC, European Commission Funding details: 2010-1984, Fondazione Cariplo Funding details: RF-2009-1529710 Funding text: The study was funded by the Italian Association for Cancer Research (AIRC) (grant no. 16921); the Italian Ministry of Health (Ricerca Finalizzata 2009, RF-2009-1529710); the European Commission (European Action Against Cancer, EPAAC, Joint Action No. 20102202); Compagnia di San Paolo (grant no. 2010.1354)?and the Cariplo Foundation (grant no. 2010-1984), Italy. References: La Vecchia, C., Malvezzi, M., Bosetti, C., Thyroid cancer mortality and incidence: a global overview (2015) Int J Cancer, 136, pp. 2187-2195; AIRTUM Working Group, Italian cancer figures, report 2014. Prevalence and cure of cancer in Italy (2014) Epidemiol Prev, 38 (6 Suppl. 1), pp. 1-144; Colonna, M., Mitton, N., Bossard, N., Total and partial cancer prevalence in the adult French population in 2008 (2015) BMC Cancer, 15, p. 153; De Moor, J.S., Mariotto, A.B., Parry, C., Cancer survivors in the United States: prevalence across the survivorship trajectory and implications for care (2013) Cancer Epidemiol Biomarkers Prev, 22, pp. 561-570; Sant, M., Allemani, C., Santaquilani, M., EUROCARE-4. Survival of cancer patients diagnosed in 1995-1999. Results and commentary (2009) Eur J Cancer, 45, pp. 931-991; Teppo, L., Hakulinen, T., Variation in survival of adult patients with thyroid cancer in Europe. EUROCARE Working Group (1998) Eur J Cancer, 34 (14 Spec No), pp. 2248-2252; Cho, H., Mariotto, A.B., Schwartz, L.M., When do changes in cancer survival mean progress? The insight from population incidence and mortality (2014) J Natl Cancer Inst Monogr, 2014, pp. 187-197; Karim-Kos, H.E., de Vries, E., Soerjomataram, I., Recent trends of cancer in Europe: a combined approach of incidence, survival and mortality for 17 cancer sites since the 1990s (2008) Eur J Cancer, 44, pp. 1345-1389; Vaccarella, S., Franceschi, S., Bray, F., Worldwide thyroid-cancer epidemic? The increasing impact of overdiagnosis (2016) New Engl J Med, 375, pp. 614-617; De Angelis, R., Sant, M., Coleman, M.P., Cancer survival in Europe 1999–2007 by country and age: results of EUROCARE-5, a population-based study (2014) Lancet Oncol, 15, pp. 23-34; Rossi, S., Baili, P., Capocaccia, R., The EUROCARE-5 study on cancer survival in Europe 1999–2007: database, quality checks and statistical analysis methods (2015) Eur J Cancer, 51, pp. 2104-2119; Parkin, D.M., Whelan, S.L., Ferlay, J., (2002) Cancer incidence in five continents, 8. , IARC Sci Publ. No. 155. IARC Lyon; Jansen, L., Castro, F.A., Gondos, A., Recent cancer survival in Germany: an analysis of common and less common cancers (2015) Int J Cancer, 136, pp. 2649-2658; Colonna, M., Uhry, Z., Guizard, A.V., Recent trends in incidence, geographical distribution, and survival of papillary thyroid cancer in France (2015) Cancer Epidemiol, 39, pp. 511-518; Amphlett, B., Lawson, Z., Abdulrahman, G.O., Jr., Recent trends in the incidence, geographical distribution, and survival from thyroid cancer in Wales, 1985-2010 (2013) Thyroid, 23, pp. 1470-1478; Londero, S.C., Krogdahl, A., Bastholt, L., Papillary thyroid carcinoma in Denmark, 1996-2008: outcome and evaluation of established prognostic scoring systems in a prospective national cohort (2015) Thyroid, 25, pp. 78-84; AIRTUM Working Group, Italian cancer figures, report 2011. Survival of cancer patients in Italy (2011) Epidemiol Prev, 35 (5/6, Suppl. 3). , http://www.registri-tumori.it/PDF/AIRTUM2011, Available at: [Accessed 14 February 2017]; Lise, M., Franceschi, S., Buzzoni, C., Changes in the incidence of thyroid cancer between 1991 and 2005 in Italy: a geographical analysis (2012) Thyroid, 22, pp. 27-34; Van den Bruel, A., Francart, J., Dubois, C., Regional variation in thyroid cancer incidence in Belgium is associated with variation in thyroid imaging and thyroid disease management (2013) J Clin Endocrinol Metab, 98, pp. 4063-4071; Ho, A.S., Davies, L., Nixon, I.J., Increasing diagnosis of subclinical thyroid cancers leads to spurious improvements in survival rates (2015) Cancer, 121, pp. 1793-1799; Pacini, F., Schlumberger, M., Dralle, H., European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium (2006) Eur J Endocrinol, 154, pp. 1-18; Haugen, B.R., Alexander, E.K., Bible, K.C., 2015 American Thyroid Association Management Guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association Guidelines task force on thyroid nodules and differentiated thyroid cancer (2016) Thyroid, 26, pp. 1-133; Janssen-Heijnen, M.L.G., Gondos, A., Bray, F., Clinical relevance of conditional survival of cancer patients in Europe: age-specific analyses of 13 cancers (2010) J Clin Oncol, 28, pp. 2520-2528; Dal Maso, L., Guzzinati, S., Buzzoni, C., Long-term survival, prevalence, and cure of cancer: a population-based estimation for 818 902 Italian patients and 26 cancer types (2014) Ann Oncol, 25, pp. 2251-2260; Micheli, A., Ciampichini, R., Oberaigner, W., The advantage of women in cancer survival: an analysis of EUROCARE-4 data (2009) Eur J Cancer, 45, pp. 1017-1027; Elisei, R., Molinaro, E., Agate, L., Are the clinical and pathological features of differentiated thyroid carcinoma really changed over the last 35 years? Study on 4187 patients from a single Italian institution to answer this question (2010) J Clin Endocr Metab, 95, pp. 1516-1527; Oyer, S.L., Smith, V.A., Lentsch, E.J., Sex is not an independent risk factor for survival in differentiated thyroid cancer (2013) Laryngoscope, 123, pp. 2913-2919; Cipriani, N.A., Nagar, S., Kaplan, S.P., Follicular thyroid carcinoma: how have histologic diagnoses changed in the last half-century and what are the prognostic implications? (2015) Thyroid, 25 (11), pp. 1209-1216; Husson, O., Haak, H.R., van Steenbergen, L.N., Rising incidence, no change in survival and decreasing mortality from thyroid cancer in The Netherlands since 1989 (2013) Endocr Relat Cancer, 20, pp. 263-271; Davies, L., Welch, H.G., Current thyroid cancer trends in the United States (2014) JAMA Otolaryngol Head Neck Surg, 140, pp. 317-322; Mariotto, A.B., Noone, A.M., Howlader, N., Cancer survival: an overview of measures, uses, and interpretation (2014) J Natl Cancer Inst Monogr, 2014, pp. 145-186; Vaccarella, S., Dal Maso, L., Laversanne, M., The impact of diagnostic changes on the rise in thyroid cancer incidence: a population-based study in selected high-resource countries (2015) Thyroid, 25 (10), pp. 1127-1136; Ahn, H.S., Kim, H.J., Kim, K.H., Thyroid cancer screening in South Korea increases detection of papillary cancers with no impact on other subtypes or thyroid cancer mortality (2016) Thyroid, 26, pp. 1535-1540; Pelizzo, M.R., Rubello, D., Bernardi, C., Thyroid surgical practices shaping thyroid cancer incidence in North-Eastern Italy (2014) Biomed Pharmacother, 68 (1), pp. 39-43; Pacini, F., Management of papillary thyroid microcarcinoma: primum non nocere! (2013) J Clin Endocrinol Metab, 98, pp. 1391-1393; Oda, H., Miyauchi, A., Ito, Y., Incidences of unfavorable events in the management of low-risk papillary microcarcinoma of the thyroid by active surveillance versus immediate surgery (2016) Thyroid, 26, pp. 150-155; Aschebrook-Kilfoy, B., James, B., Nagar, S., Kaplan, S., Seng, V., Ahsan, H., Risk factors for decreased quality of life in thyroid cancer survivors: initial findings from the North American thyroid cancer survivorship study (2015) Thyroid, 25 (12), pp. 1313-1321; Lubitz, C.C., Kong, C.Y., McMahon, P.M., Daniels, G.H., Chen, Y., Economopoulos, K.P., Annual financial impact of well-differentiated thyroid cancer care in the United States (2014) Cancer, 120 (9), pp. 1345-1352; Husson, O., Haak, H.R., Oranje, W.A., Health-related quality of life among thyroid cancer survivors: a systematic review (2011) Clin Endocrinol, 75, pp. 544-554
PY - 2017
Y1 - 2017
N2 - Background Incidence rates of thyroid cancer (TC) increased in several countries during the last 30 years, while mortality rates remained unchanged, raising important questions for treatment and follow-up of TC patients. This study updates population-based estimates of relative survival (RS) after TC diagnosis in Europe by sex, country, age, period and histology. Methods Data from 87 cancer registries in 29 countries were extracted from the EUROCARE-5 dataset. One- and 5-year RS were estimated using the cohort approach for 86,690 adult TC patients diagnosed in 2000–2007 and followed-up to 12/31/2008. RS trends in 1999–2007 and 10-year RS in 2005–2007 were estimated using the period approach. Results In Europe 2000–2007, 5-year RS after TC was 88% in women and 81% in men. Survival rates varied by country and were strongly correlated (Pearson ρ = 75%) with country-specific incidence rates. Five-year RS decreased with age (in women from >95% at age 15–54 to 57% at age 75+), from 98% in women and 94% in men with papillary TC to 14% in women and 12% in men with anaplastic TC. Proportion of papillary TC varied by country and increased over time, while survival rates were similar across areas and periods. In 1999–2007, 5-year RS increased by five percentage points for all TCs but only by two for papillary and by four for follicular TC. Ten-year RS in 2005–2007 was 89% in women and 79% in men. Conclusions The reported increasing TC survival trend and differences by area are mainly explained by the varying histological case-mix of cases. © 2017 Elsevier Ltd
AB - Background Incidence rates of thyroid cancer (TC) increased in several countries during the last 30 years, while mortality rates remained unchanged, raising important questions for treatment and follow-up of TC patients. This study updates population-based estimates of relative survival (RS) after TC diagnosis in Europe by sex, country, age, period and histology. Methods Data from 87 cancer registries in 29 countries were extracted from the EUROCARE-5 dataset. One- and 5-year RS were estimated using the cohort approach for 86,690 adult TC patients diagnosed in 2000–2007 and followed-up to 12/31/2008. RS trends in 1999–2007 and 10-year RS in 2005–2007 were estimated using the period approach. Results In Europe 2000–2007, 5-year RS after TC was 88% in women and 81% in men. Survival rates varied by country and were strongly correlated (Pearson ρ = 75%) with country-specific incidence rates. Five-year RS decreased with age (in women from >95% at age 15–54 to 57% at age 75+), from 98% in women and 94% in men with papillary TC to 14% in women and 12% in men with anaplastic TC. Proportion of papillary TC varied by country and increased over time, while survival rates were similar across areas and periods. In 1999–2007, 5-year RS increased by five percentage points for all TCs but only by two for papillary and by four for follicular TC. Ten-year RS in 2005–2007 was 89% in women and 79% in men. Conclusions The reported increasing TC survival trend and differences by area are mainly explained by the varying histological case-mix of cases. © 2017 Elsevier Ltd
KW - Cancer registries
KW - EUROCARE
KW - Europe
KW - Papillary
KW - Relative survival
KW - Thyroid cancer
KW - adult
KW - age
KW - Article
KW - cancer diagnosis
KW - cancer incidence
KW - cancer mortality
KW - cancer registry
KW - cancer survival
KW - cohort analysis
KW - Croatia
KW - female
KW - France
KW - human
KW - Ireland
KW - major clinical study
KW - male
KW - mortality rate
KW - Northern European
KW - oncological parameters
KW - priority journal
KW - relative survival
KW - sex
KW - Southern Europe
KW - survival rate
KW - survival time
KW - thyroid cancer
KW - thyroid papillary carcinoma
KW - adenocarcinoma
KW - adolescent
KW - aged
KW - carcinoma
KW - clinical trial
KW - demography
KW - diagnosis related group
KW - epidemiology
KW - incidence
KW - middle aged
KW - mortality
KW - multicenter study
KW - register
KW - sex ratio
KW - statistics and numerical data
KW - thyroid tumor
KW - young adult
KW - Adenocarcinoma, Follicular
KW - Adolescent
KW - Adult
KW - Aged
KW - Carcinoma
KW - Diagnosis-Related Groups
KW - Female
KW - Humans
KW - Incidence
KW - Male
KW - Middle Aged
KW - Registries
KW - Residence Characteristics
KW - Sex Distribution
KW - Thyroid Neoplasms
KW - Young Adult
U2 - 10.1016/j.ejca.2017.02.023
DO - 10.1016/j.ejca.2017.02.023
M3 - Article
VL - 77
SP - 140
EP - 152
JO - European Journal of Cancer
JF - European Journal of Cancer
SN - 0959-8049
ER -